Zweig DiMenna Associates LLC Has $5.74 Million Stake in Synopsys, Inc. $SNPS

Zweig DiMenna Associates LLC trimmed its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 37.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,479 shares of the semiconductor company’s stock after selling 8,521 shares during the quarter. Zweig DiMenna Associates LLC’s holdings in Synopsys were worth $5,741,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sankala Group LLC bought a new position in shares of Synopsys during the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Synopsys in the fourth quarter valued at about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys in the fourth quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new stake in Synopsys in the fourth quarter valued at about $32,000. Finally, Osbon Capital Management LLC acquired a new position in Synopsys in the fourth quarter worth about $34,000. 85.47% of the stock is owned by institutional investors.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on SNPS shares. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Bank of America upped their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Rosenblatt Securities increased their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Needham & Company LLC restated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Finally, Morgan Stanley boosted their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $570.06.

Check Out Our Latest Stock Report on Synopsys

Synopsys Trading Down 1.8%

Shares of SNPS stock opened at $425.90 on Wednesday. The company has a market capitalization of $81.55 billion, a P/E ratio of 98.59, a P/E/G ratio of 2.55 and a beta of 1.22. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average price of $475.30 and a 200 day moving average price of $459.92.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.